ASCO and Cancer Foundation Recognize Community Oncology Practices’ Dedication to Clinical Research
Thursday, 08 May 2008
ALEXANDRIA, VA, USA (Press Release) – May 8, 2008
read more
|
UroToday Inc. Launches a Unique “No Cost” Online Open Access Journal Focused on Urology and Urologic Oncology
Tuesday, 06 May 2008
BERKELEY, CA, USA (Press Release) - UroToday International Journal® offers authors the ability to submit manuscripts for peer-review free of charge and readers access to full text articles free of charge.
read more
|
The ASCO Cancer Foundation Awards $7.6 Million to Further Progress Against Cancer
Tuesday, 06 May 2008
ALEXANDRIA, VA, USA (Press Release) - May 6, 2008
read more
|
Genetic Variation in Hormone Metabolizing Genes and Risk of Testicular Germ Cell Tumors - Abstract
Wednesday, 30 April 2008
Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
read more
|
Recent Developments in Germ Cell Tumors of the Testes - Abstract
Monday, 28 April 2008
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
read more
|
Recent Developments in Urologic Oncology: Positron Emission Tomography Molecular Imaging - Abstract
Monday, 28 April 2008
PET & Cyclotron Unit, Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
read more
|
Testicular Tumors - Some New and a Few Perennial Problems - Abstract
Wednesday, 16 April 2008
The histopathology of testicular tumors is presented, emphasizing new, unusual, or underemphasized aspects.
read more
|
Chronic Cancer-Related Fatigue in Long-Term Survivors of Testicular Cancer - Abstract
Monday, 14 April 2008
Department of Biological and Medical Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.
read more
|
Racial Differences Among Boys With Testicular Germ Cell Tumors in the United States - Abstract
Friday, 11 April 2008
Departments of Urology, Obstetrics, Gynecology and Reproductive Sciences (MSC, PJT), UCSF Comprehensive Cancer Center (PRC, PJT), University of California San Francisco, San Francisco, California.
read more
|
Medical Malpractice in American Urology: 22-Year National Review of the Impact of Caps and Implications for Contemporary Practice - Abstract
Monday, 07 April 2008
Department of Urology, Baylor College of Medicine (MHH), Houston, Texas.
read more
|
EAU 2008 - Molecular Detection of Lymph Node Involvement in Genitourinary Cancer
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - Dr. Michael Jewett (Toronto) presented the SIU lecture on detection and mapping regional lymph nodes (LN) in genitourinary cancer. He addressed the importance of LN in staging and therapy of GU cancers.
Login to read more...
|
EAU 2008 - The Use of Biological Markers in Clinical Practice
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - Dr. Bjartell (Lund) presented on the use of biological markers as they can apply to clinical practice.
Login to read more...
|
EAU 2008 - Advances in Targeted Therapy and Tissue Engineering in Urology
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - Dr. Evans (Sacramento) presented a lecture on targeted therapies. Most drugs have a mechanistic “target”, such as the enzymes 5-α reductase in the treatment of BPH or 5-phosphodiesterase in the treatment of erectile dysfunction. However, in the current presentation, “targeted therapy” is defined as molecular targeting.
Login to read more...
|
EAU 2008 - Advances in Targeted Therapy and Tissue Engineering in Urology: Targeted Therapy
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - When a patient comes to the pharmacist in the future he may state: “Here is my sequence”. This could be a consequence of the development of targeted therapies as presented by Chris Evans. He pointed out that molecular profile of a patient will have an increasing impact on the selection patients for a diagnostic procedure or even a specific therapy.
Login to read more...
|
EAU 2008 - Management of the Retroperitoneum after Chemotherapy in Testicular Cancer: The Role and Extent of Surgery
Monday, 31 March 2008
MILAN, ITALY (UroToday.com) - Professor Droz (Lyon) moderated a debate on the retroperitoneum (RP) in testes cancer. Professor Albers (Kassel) presented the argument that post-chemotherapy RPLND is indicated in almost all patients.
Login to read more...
|
Testicular Cancer 
